Chromium picolinate supplementation improves insulin sensitivity in Goto-Kakizaki diabetic rats (Q44893370)

7 December 2017

Chromium picolinate supplementation improves insulin sensitivity in Goto-Kakizaki diabetic rats (English)

1 reference

7 December 2017

1 reference

Dong-Sun Kim

1

1 reference

PubMed ID

15139386

7 December 2017

Tae-Wha Kim

series ordinal

2

1 reference

PubMed ID

15139386

7 December 2017

Ju-Seop Kang

series ordinal

3

1 reference

7 December 2017

1 January 2004

1 reference

Journal of Trace Elements in Medicine and Biology

7 December 2017

1 reference

7 December 2017

17

1 reference

7 December 2017

243-247

1 reference

7 December 2017

4

1 reference

Chromium(III) and the glucose tolerance factor

7 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0946-672X%2804%2980025-7

7 January 2021

Dietary chromium decreases insulin resistance in rats fed a high-fat, mineral-imbalanced diet.

1 reference

https://api.crossref.org/works/10.1016%2FS0946-672X%2804%2980025-7

7 January 2021

Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0946-672X%2804%2980025-7

7 January 2021

Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0946-672X%2804%2980025-7

7 January 2021

Chromium deficiency after long-term total parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0946-672X%2804%2980025-7

7 January 2021

Overproduction of insulin in the chromium-deficient rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0946-672X%2804%2980025-7

7 January 2021

Effect of Inorganic chromium supplementation on glucose tolerance, insulin response, and serum lipids in noninsulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0946-672X%2804%2980025-7

7 January 2021

The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0946-672X%2804%2980025-7

7 January 2021

Use of the artificial beta cell (ABC) in the assessment of peripheral insulin sensitivity: effect of chromium supplementation in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0946-672X%2804%2980025-7

7 January 2021

Chromium as a supplement

1 reference

https://api.crossref.org/works/10.1016%2FS0946-672X%2804%2980025-7

7 January 2021

Chromium homeostasis in patients with type II (NIDDM) diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0946-672X%2804%2980025-7

7 January 2021

Chromium improves insulin response to glucose in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0946-672X%2804%2980025-7

7 January 2021

Development of diabetes in the non-obese NIDDM rat (GK rat)

1 reference

https://api.crossref.org/works/10.1016%2FS0946-672X%2804%2980025-7

7 January 2021

Lack of toxicity of chromium chloride and chromium picolinate in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0946-672X%2804%2980025-7

7 January 2021

Lack of effect of dietary chromium supplementation on glucose tolerance, plasma insulin and lipoprotein levels in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0946-672X%2804%2980025-7

7 January 2021

Comparison and Effects of Natural and Synthetic Glucose Tolerance Factor in Normal and Genetically Diabetic Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0946-672X%2804%2980025-7

7 January 2021

Quest for the molecular mechanism of chromium action and its relationship to diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0946-672X%2804%2980025-7

7 January 2021

Isolation of a biologically active low-molecular-mass chromium compound from rabbit liver

1 reference

https://api.crossref.org/works/10.1016%2FS0946-672X%2804%2980025-7

7 January 2021

Chromium oligopeptide activates insulin receptor tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0946-672X%2804%2980025-7

7 January 2021

Effects of chromium on body composition and weight loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0946-672X%2804%2980025-7

7 January 2021

Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body composition in healthy, nonobese, older men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0946-672X%2804%2980025-7

7 January 2021

Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body weight in dexamethasone-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0946-672X%2804%2980025-7

7 January 2021

10.1016/S0946-672X(04)80025-7

Identifiers

DOI

1 reference

7 December 2017

1 reference

PubMed ID

15139386